ISIS 3521
CDR0000068686
Phase 3 mab completed
Quick answer
ISIS 3521 for Lung Cancer is a Phase 3 program (mab) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Lung Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed